Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 24, 2006

Stroke. 2006
Published online before print August 24, 2006, doi: 10.1161/01.STR.0000239659.99112.fb
A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/10/2540    most recent
01.STR.0000239659.99112.fbv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pretnar-Oblak, J.
Right arrow Articles by Zaletel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pretnar-Oblak, J.
Right arrow Articles by Zaletel, M.
Related Collections
Right arrow Secondary prevention
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Cerebral Lacunes
Right arrow Other Stroke Treatment - Medical
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

Submitted on April 15, 2006
Revised on June 22, 2006
Accepted on July 18, 2006

Influence of Atorvastatin Treatment on L-Arginine Cerebrovascular Reactivity and Flow-Mediated Dilatation in Patients With Lacunar Infarctions

Janja Pretnar-Oblak MD, PhD*; Miso Sabovic MD, PhD; Miran Sebestjen MD, PhD; Tomaz Pogacnik MD, PhD; and Marjan Zaletel MD, PhD

From the Ljubljana Medical Centre, Department of Neurology, Ljubljana, Slovenia.

* To whom correspondence should be addressed. E-mail: janja.pretnar{at}kclj.si.

Background and Purpose--In our study we hypothesized that statins improve endothelial function in patients with lacunar infarctions (LI). Cerebral and systemic endothelial function was determined before and after 3-months treatment with atorvastatin.

Methods--Cerebral endothelial function was determined by L-arginine reactivity and systemic endothelial function by flow-mediated dilatation (FMD) in patients with LI (18 patients, aged 61.1±7.6 years), 20 age- and gender-matched patients with similar risk factors (SR) and 19 age- and gender-matched healthy controls. The mean arterial velocity (vm) in both middle cerebral arteries was measured by transcranial Doppler sonography before, during and after a 30-minute intravenous infusion of L-arginine. FMD of the brachial artery after hyperaemia was determined. The measurements were repeated after 3-months treatment with 40 mg of atorvastatin per day.

Results--L-arginine reactivity was decreased in LI patients (13.1±8.4%) and in patients with SR compared with healthy controls (P≤0.01). FMD was more impaired in patients with LI (0.06±4.9%) compared with patients with SR and healthy controls (P≤0.01). After atorvastatin treatment, L-arginine reactivity and FMD improved in both patients with LI (17.1±7.6%; 7.0±5.7%) and patients with SR (P≤0.01). Previously mildly increased cholesterol values normalized.

Conclusion--The decreased L-arginine reactivity and FMD improve after atorvastatin treatment in both patients with LI and patients with SR.


Key words: endothelium • lacunar infarction • risk factors • statins • transcranial Doppler sonography


Related Article:

Statins and Cerebral Vasomotor Reactivity: Implications for a New Therapy?
Francisco Javier Carod-Artal
Stroke 2006 37: 2446-2448. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
P. C. Lavallee, J. Labreuche, F. Gongora-Rivera, A. Jaramillo, D. Brenner, I. F Klein, P.-J. Touboul, E. Vicaut, P. Amarenco, and on behalf of the Lacunar-B.I.C.H.A.T. Investigator
Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease
Stroke, May 1, 2009; 40(5): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. M. Wardlaw, A. Farrall, P. A. Armitage, T. Carpenter, F. Chappell, F. Doubal, D. Chowdhury, V. Cvoro, and M. S. Dennis
Changes in Background Blood-Brain Barrier Integrity Between Lacunar and Cortical Ischemic Stroke Subtypes
Stroke, April 1, 2008; 39(4): 1327 - 1332.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. J. Carod-Artal
Statins and Cerebral Vasomotor Reactivity: Implications for a New Therapy?
Stroke, October 1, 2006; 37(10): 2446 - 2448.
[Full Text] [PDF]